President , Director , Member , Secretary, Treasurer, Vice-President:
Albert E. Raizner (President , Director , Member , Secretary, Treasurer, Vice-President)
TIN:
32036052135
Professional information
Dr. Albert E Raizner - MD (Doctor of Medicine)
Hospitals:
Interventional Cardiology Assoc 6550 Fannin St STE 2021, Houston 77030 The Methodist Hospital 6565 Fannin St, Houston 77030 Interventional Cardiology Assoc 6550 Fannin St STE 2021, Houston 77030 The Methodist Hospital 6565 Fannin St, Houston 77030
Education:
Medical Schools Suny Downstate Medical Center Graduated: 1967
Albert E Raizner, Houston TX
Specialties:
Cardiologist
Address:
6550 Fannin St, Houston, TX 77030
Education:
State University of New York Downstate Medical Center, College of Medicine - Doctor of Medicine Emory University Hospital - Fellowship - Cardiology Maimonides Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Interventional Cardiology (Internal Medicine)
Radioactive Source Wire, Apparatus And Treatment Methods
US Patent:
6506145, Jan 14, 2003
Filed:
Jun 6, 1995
Appl. No.:
08/467711
Inventors:
Anthony J. Bradshaw - Missouri City TX Steven L. Weinberg - League City TX Albert E. Raizner - Houston TX
Assignee:
Advanced Cardiovascular Systems, Inc. - Santa Clara CA
International Classification:
A61N 500
US Classification:
600 3
Abstract:
A source wire having a radioactive source at its distal tip is used to treat a blood vessel within a patients body by localized in vivo radiation to prevent stenosis of the blood vessel, including restenosis following percutaneous transluminal coronary angioplasty. The source wire is advanced to the target site along the intravascular system of the patients body from a point external to the body. The source wire is preferably a solid lead of substantially uniform thickness along its entire length, composed of a superelastic nickel-titanium alloy (nitinol). Alternatively, the wire may be a cable composed of multiple strands of the alloy of substantially uniform thickness throughout the entire length of each strand. The alloy has desired characteristics of superelasticity for transitioning into and out of a stress-induced martensitic state as it is advanced through tortuous lumens for passage into the coronary arteries. The wire also is of a diameter suitable for passage into the coronary arteries, and the distal end of the wire may be tapered for ease of entry into narrowed portions.
Method Of Treating A Body Vessel Or Duct With Radiation From Within The Lumen
US Patent:
6283910, Sep 4, 2001
Filed:
Feb 7, 1996
Appl. No.:
8/644101
Inventors:
Anthony J. Bradshaw - Missouri City TX Steven L. Weinberg - League City TX Albert E. Raizner - Houston TX
International Classification:
A61N 500
US Classification:
600 3
Abstract:
A source wire having a radioactive source at its distal tip is used to treat tissue at a target site within a patient's body by localized in vivo radiation. The source wire is advanced to the target site along the intravascular system of the patient's body from a point external to the body. The source wire is a solid lead of substantially uniform thickness along its entire length, composed of nickel-titanium alloy (nitinol). Alternatively, the wire may be a cable composed of multiple strands of the alloy of substantially uniform thickness throughout the entire length of each strand. The alloy has desired characteristics including flexibility, springiness, slipperiness, mechanical strength and shape memory retention, and the source wire is imparted with certain stressed and unstressed states that depend on flexation of the wire and a prescribed transition temperature. The wire has a diameter suitable for passage into the coronary arteries, and the distal end of the wire is tapered for ease of entry into narrowed portions. The tissue to be treated lies along a portion of the interior surface of a coronary artery which has been subjected to an angioplasty procedure to reduce blockage of the lumen and thereby improve blood flow.
Method Of Treating A Body Vessel Or Duct With Radiation From Within The Lumen
US Patent:
2002006, May 30, 2002
Filed:
Sep 4, 2001
Appl. No.:
09/944200
Inventors:
Anthony Bradshaw - Missouri City TX, US Steven Weinberg - League City TX, US Albert Raizner - Houston TX, US John Edison - Houston TX, US
International Classification:
A61N005/00
US Classification:
600/003000
Abstract:
A method is disclosed to treat the wall of a blood vessel from within the lumen thereof with a radiation catheter that includes a working or radiotherapy lumen, a longitudinally channeled distal balloon, and a balloon inflation lumen. The method includes steps of inserting the catheter into the vessel lumen until the balloon is adjacent a target site of the vessel wall to be treated, inflating the balloon to substantially center the catheter radiotherapy lumen within the vessel lumen at the target site while allowing perfusion of blood past the inflated balloon through channels formed by the balloon, advancing a radioactive source into the catheter radiotherapy lumen to position the source within a region of that lumen along a portion of the catheter occupied by the balloon; and withdrawing the source after it has been positioned within that region of the radiotherapy lumen for a predetermined interval of time.
Method And Device For Performing Transluminal Angioplasty
US Patent:
4651738, Mar 24, 1987
Filed:
Aug 2, 1985
Appl. No.:
6/762081
Inventors:
Linda L. Demer - Houston TX Avanindra Jain - Houston TX Albert E. Raizner - Houston TX Craig J. Hartley - Houston TX
Assignee:
Baylor College of Medicine - Houston TX
International Classification:
A61M 2902
US Classification:
128344
Abstract:
A novel method and device for performing percutaneous transluminal angioplasty to treat occlusive artery disease is disclosed. The method involves simultaneous measurement and display of the fluid pressure and volume existing within the balloon catheter as the procedure is performed. Information is produced which is useful in determining the efficacy of the procedure as it is performed which obviates the need for arbitrary repeated inflations. The information is also useful in the subsequent management of the patient's disease.
Adenoviral Vector For Inhibiting Restenosis
US Patent:
6290949, Sep 18, 2001
Filed:
May 28, 1996
Appl. No.:
8/653824
Inventors:
Brent A. French - Houston TX Albert E. Raizner - Houston TX Robert Roberts - Houston TX
International Classification:
A61K 4800, A01N 6300, C12N 1500
US Classification:
424 932
Abstract:
Gene transfer vectors, especially adenoviral vectors, and synthetic vectors capable of emulating specific viral functions, that carry gene sequences capable of ameliorating or preventing the symptoms of cardiovascular disease are disclosed. Such methods can be used to treat restenosis, especially when incident to injury by angioplasty.
Method And Apparatus For Uniform Radiation Treatment Of Vascular Lumens
US Patent:
5643171, Jul 1, 1997
Filed:
Nov 15, 1994
Appl. No.:
8/339950
Inventors:
Anthony J. Bradshaw - Missouri City TX Albert E. Raizner - Houston TX
Assignee:
NeoCardia, LLC - Houston TX
International Classification:
A61N 500
US Classification:
600 1
Abstract:
A method and apparatus for intravascular radiotherapy for prevention of stenosis following angioplasty or other trauma to coronary arteries caused by smooth muscle cell hyperplasia in which a uniform dosage of radiation is delivered to the walls of the artery by positively positioning a radioactive source at the radial center of the artery being treated.